This inventor holds 1 USPTO granted patent. Top assignee: Sail Biomedicines. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: John Mancuso and His Patent on AHR Antagonists.
Introduction
John Mancuso is an inventor based in Ste. Marthe-sur-le-Lac, Canada, and is associated with Sail Biomedicines. His patent work concerns compounds that may have applications in cancer treatment and disorders involving abnormal immune responses.
Latest Patents
Mancuso is associated with 1 patent: “Pyridopyrimidinone Derivatives as AHR Antagonists.” The disclosure covers compounds of formula (Ia), their pharmaceutically acceptable salts, pharmaceutical compositions, preparation methods, and useful intermediate compounds. It also describes potential methods for treating or preventing diseases, particularly cancer and conditions associated with dysregulated immune responses or aberrant AHR signaling. The compounds may also be investigated for use alongside at least one additional therapy.
Career Highlights
Mancuso’s listed patent activity connects his work with medicinal chemistry and therapeutic research. The patent describes a range of potential applications, including cancer treatment and conditions linked to AHR signaling.
Collaborations
The patent information names Alessandra Bartolozzi and John Robert Proudfoot among Mancuso’s coworkers. His company affiliation is Sail Biomedicines.
Conclusion
John Mancuso’s patent focuses on pyridopyrimidinone derivatives as AHR antagonists and outlines their potential role in treating cancer and other disorders associated with abnormal AHR signaling.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile